white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to
Pay in 4 interest-free payments of $5.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to](https://www.drugdiscoverytrends.com/wp-content/uploads/2025/11/trump.webp)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to](https://cdn.jwplayer.com/v2/media/EY4ZFCT5/poster.jpg?width=1280)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to](https://static.independent.co.uk/2026/02/06/0/22/SEI283706526.jpg)
![white house glp-1 The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Trump administration makes deal to](https://digbihealth.com/cdn/shop/articles/Untitled_872b1ef3-e86e-495b-a53e-4354fd11b406_1000x.jpg?v=1762619859)





















